Azithromycin Injection — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Azithromycin Injection (injection) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on Jan 20, 2026.

Shortage details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0069-3150-83
Dosage Form
Injection
Presentation
Zithromax IV, Injection, 500 mg/5 mL (NDC 0069-3150-83)
Initial Posting
Jan 20, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.